Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danielle Bradshaw

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Kansas Journal of Medicine|April 3, 2019
Maternal Knowledge, Attitudes, and Practices Concerning Interpregnancy IntervalCarolyn R Ahlers-Schmidt, Nikki Keene Woods, Danielle Bradshaw, et al.
The Journal of the American Osteopathic Association|September 23, 2008
Intraobserver reliability of cranial strain patterns as evaluated by osteopathic physicians: a pilot studyKelly D Halma, Brian F Degenhardt, Karen T Snider, et al.
Hematology Reports|July 25, 2024
Identifying Candidates for Effective Utilization of Stored Autologous PBSCs in Salvage Transplantation for Multiple Myeloma: Who Benefits Most?Amany R Keruakous, Laura Walker, Molly Denlinger, et al.
Ejhaem|August 19, 2024
Real-world outcomes of intensive induction approaches in core binding factor acute myeloid leukemiaAlexandra E Rojek, Benjamin J McCormick, Joanna Cwykiel, et al.
Leukemia|February 22, 2023
Survival of TP53-mutated acute myeloid leukemia patients receiving allogeneic stem cell transplantation after first induction or salvage therapy: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)Talha Badar, Ehab Atallah, Rory Shallis, et al.
American Journal of Hematology|February 12, 2024
Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real-world data from eight US academic centersYasmin Abaza, Eric S Winer, Guru Subramanian Guru Murthy, et al.
Cancer|December 22, 2022
Disparities in receiving disease-directed therapy, allogeneic stem cell transplantation in non-Hispanic Black patients with TP53-mutated acute myeloid leukemiaTalha Badar, Mark R Litzow, Rory M Shallis, et al.
Haematologica|May 30, 2024
Prognostic impact of 'multi-hit' <i>versus</i> 'single-hit' <i>TP53</i> alteration in patients with acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic DiseasesTalha Badar, Ahmad Nanaa, Ehab Atallah, et al.
Journal of Medical Virology|September 7, 2023
Ethno-demographic disparities in humoral responses to the COVID-19 vaccine among healthcare workersPankaj Ahluwalia, Ashutosh Vashisht, Harmanpreet Singh, et al.
JAMA Oncology|February 27, 2025
Academic Community Partnership in Acute Promyelocytic Leukemia and Early Mortality: The ECOG-ACRIN EA9131 TrialAnand P Jillella, Sandra J Lee, Jessica K Altman, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Kansas Journal of Medicine|April 3, 2019
Maternal Knowledge, Attitudes, and Practices Concerning Interpregnancy IntervalCarolyn R Ahlers-Schmidt, Nikki Keene Woods, Danielle Bradshaw, et al.
The Journal of the American Osteopathic Association|September 23, 2008
Intraobserver reliability of cranial strain patterns as evaluated by osteopathic physicians: a pilot studyKelly D Halma, Brian F Degenhardt, Karen T Snider, et al.
Hematology Reports|July 25, 2024
Identifying Candidates for Effective Utilization of Stored Autologous PBSCs in Salvage Transplantation for Multiple Myeloma: Who Benefits Most?Amany R Keruakous, Laura Walker, Molly Denlinger, et al.
Ejhaem|August 19, 2024
Real-world outcomes of intensive induction approaches in core binding factor acute myeloid leukemiaAlexandra E Rojek, Benjamin J McCormick, Joanna Cwykiel, et al.
Leukemia|February 22, 2023
Survival of TP53-mutated acute myeloid leukemia patients receiving allogeneic stem cell transplantation after first induction or salvage therapy: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)Talha Badar, Ehab Atallah, Rory Shallis, et al.
American Journal of Hematology|February 12, 2024
Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real-world data from eight US academic centersYasmin Abaza, Eric S Winer, Guru Subramanian Guru Murthy, et al.
Cancer|December 22, 2022
Disparities in receiving disease-directed therapy, allogeneic stem cell transplantation in non-Hispanic Black patients with TP53-mutated acute myeloid leukemiaTalha Badar, Mark R Litzow, Rory M Shallis, et al.
Haematologica|May 30, 2024
Prognostic impact of 'multi-hit' <i>versus</i> 'single-hit' <i>TP53</i> alteration in patients with acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic DiseasesTalha Badar, Ahmad Nanaa, Ehab Atallah, et al.
Journal of Medical Virology|September 7, 2023
Ethno-demographic disparities in humoral responses to the COVID-19 vaccine among healthcare workersPankaj Ahluwalia, Ashutosh Vashisht, Harmanpreet Singh, et al.
JAMA Oncology|February 27, 2025
Academic Community Partnership in Acute Promyelocytic Leukemia and Early Mortality: The ECOG-ACRIN EA9131 TrialAnand P Jillella, Sandra J Lee, Jessica K Altman, et al.
Pageof 2